Emtricitabine
Composition
The formulation contains Emtricitabine 200 mg with microcrystalline cellulose, sodium starch glycolate, magnesium stearate, and gelatin as the active ingredient.
Indications
Indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents.
Side effects
Common side effects include headache, diarrhea, nausea, fatigue, and skin discoloration.
Precautions
Monitor liver function, renal function, and signs of lactic acidosis; use with caution in patients with renal impairment or hepatic disease; avoid concurrent use with other nephrotoxic drugs.
Contraindications
Known hypersensitivity to emtricitabine or its components
Dosage and administration
200 mg once daily, with or without food
Countries
USA, South Africa, India
Available Forms
Capsules, oral solution
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai